4.5 Article

Triazolyl Azabicyclo[3.1.0]hexanes: a Class of Potent and Selective Dopamine D3 Receptor Antagonists

Journal

CHEMMEDCHEM
Volume 5, Issue 5, Pages 705-715

Publisher

WILEY-BLACKWELL
DOI: 10.1002/cmdc.201000026

Keywords

azabicyclo[3.1.0]hexanes; dopamine D-3 antagonists; hERG channel; receptors

Ask authors/readers for more resources

Herein we report a detailed description of the structure activity relationships for a novel series of C-linked 1,2,4-triazolylazabicyclo[3.1.0]hexanes. These derivatives are endowed with very high in vitro affinity and selectivity for the dopamine D-3 receptor. An optimization with respect to undesired affinity toward the hERG potassium channel is also reported. Members of this compound series also show excellent in vitro and in vivo pharmacokinetic properties.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists

Fabrizio Micheli, Andrea Bernardelli, Federica Bianchi, Simone Braggio, Laura Castelletti, Palmina Cavallini, Paolo Cavanni, Susanna Cremonesi, Michele Dal Cin, Aldo Feriani, Beatrice Oliosi, Teresa Semeraro, Luca Tarsi, Silvia Tomelleri, Andrea Wong, Filippo Visentini, Laura Zonzini, Christian Heidbreder

BIOORGANIC & MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists

Fabrizio Micheli, Susanna Cremonesi, Teresa Semeraro, Luca Tarsi, Silvia Tomelleri, Paolo Cavanni, Beatrice Oliosi, Elisabetta Perdona, Anna Sava, Laura Zonzini, Aldo Feriani, Simone Braggio, Christian Heidbreder

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Article Chemistry, Medicinal

1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists

Fabrizio Micheli, Alessia Bacchi, Simone Braggio, Laura Castelletti, Palmina Cavallini, Paolo Cavanni, Susanna Cremonesi, Michele Dal Cin, Aldo Feriani, Sylvie Gehanne, Mahmud Kajbaf, Luciano Marchio, Selena Nola, Beatrice Oliosi, Annalisa Pellacani, Elisabetfa Perdona, Anna Sava, Teresa Semeraro, Luca Tarsi, Silvia Tomelleri, Andrea Wong, Filippo Visentini, Laura Zonzini, Christian Heidbreder

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors

Fabrizio Micheli, Paolo Cavanni, Michela Bettati, Giorgio Bonanomi, Romano Di Fabio, Elettra Fazzolari, Carla Marchioro, Maja Roscic, Luca Tarsi, Filippo Visentini, Laura Zonzini, Angela Worby

BIOORGANIC & MEDICINAL CHEMISTRY (2011)

Article Chemistry, Medicinal

Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: Novel, potent, and selective series of Vasopressin1b receptor antagonists

Roberto Arban, Federica Bianchi, Alberto Buson, Susanna Cremonesi, Romano Di Fabio, Gabriella Gentile, Fabrizio Micheli, Alessandra Pasquarello, Alfonso Pozzan, Luca Tarsi, Silvia Terreni, Federica Tonelli

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Article Chemistry, Medicinal

Oxa-azaspiro Derivatives: a Novel Class of Triple Re-uptake Inhibitors

Michela Bettati, Paolo Cavanni, Romano Di Fabio, Beatrice Oliosi, Ornella Perini, Gunther Scheid, Giovanna Tedesco, Laura Zonzini, Fabrizio Micheli

CHEMMEDCHEM (2010)

Article Chemistry, Medicinal

Targeting Cystalysin, a Virulence Factor of Treponema denticola-Supported Periodontitis

Francesca Spyrakis, Barbara Cellini, Stefano Bruno, Paolo Benedetti, Emanuele Carosati, Gabriele Cruciani, Fabrizio Micheli, Antonio Felici, Pietro Cozzini, Glen E. Kellogg, Carla Borri Voltattorni, Andrea Mozzarelli

CHEMMEDCHEM (2014)

Review Chemistry, Medicinal

Dopamine D3 receptor antagonists: a patent review (2007-2012)

Fabrizio Micheli, Christian Heidbreder

EXPERT OPINION ON THERAPEUTIC PATENTS (2013)

Article Chemistry, Medicinal

Further Insights in 5-phenyl-2-[2-(1-piperidinylcarbonyl) Phenyl]-2,3-dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones, a Recently Disclosed Class of Neuropeptide S Antagonists

Gabriele Costantino, Marco Mor, Chiara Pecchini, Gian Paolo Vallerini, Elisa Della Turca, Fabrizio Micheli, Angela Worby, Romano Di Fabio, Angelo Giacometti, Adelheid Roth, Emilio Merlo-Pich, Matteo Biagetti, Giorgio Bonanomi, Dino Montanari, Luca Tarsi, Federica Tonelli, Raffaele Longhi, Anna Maria Capelli

LETTERS IN DRUG DESIGN & DISCOVERY (2013)

Article Neurosciences

Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach

Manolo Mugnaini, Laura Iavarone, Palmina Cavallini, Cristiana Griffante, Beatrice Oliosi, Chiara Savoia, John Beaver, Eugenii A. Rabiner, Fabrizio Micheli, Christian Heidbreder, Anne Andorn, Emilio Merlo Pich, Massimo Bani

NEUROPSYCHOPHARMACOLOGY (2013)

Article Chemistry, Medicinal

Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems

Alessandro Grillo, Giulia Chemi, Simone Brogi, Margherita Brindisi, Nicola Relitti, Filomena Fezza, Domenico Fazio, Laura Castelletti, Elisabetta Perdona, Andrea Wong, Stefania Lamponi, Alessandra Pecorelli, Mascia Benedusi, Manuela Fantacci, Massimo Valoti, Giuseppe Valacchi, Fabrizio Micheli, Ettore Novellino, Giuseppe Campiani, Stefania Butini, Mauro Maccarrone, Sandra Gemma

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Pharmacology & Pharmacy

Triple monoamine uptake inhibitors

Anna Maria Capelli, Fabrizio Micheli

PHARMACEUTICAL PATENT ANALYST (2012)

No Data Available